Senior Regulatory Program Manager, Immunology - Hybrid

Johnson & Johnson Co.; Spring House (PA); On-site; USD 112,000 - 181,000; Full time

Job summary

Johnson & Johnson in the United States seeks a Senior Analyst, Regulatory Program Manager (Immunology) to drive operational delivery of RPM services. You will coordinate cross-functional efforts with GRL, GRT, and partners to ensure quality, speed and alignment with program goals across multiple sites.

You will translate regulatory strategy into executable plans, manage budgets, and lead process improvements to enable accelerated filings and launches in a fast-moving immunology portfolio.

Qualifications

• Bachelor's degree required; advanced degree preferred.
• Minimum 4 years of industry/business experience in pharma/medtech.
• Project management experience in a matrix, cross-functional setting.
• Strong written and verbal communication; strategic thinking.
• Ability to translate strategy into executable plans and manage risk.

Responsibilities

• Lead operational execution of regulatory programs and health authority filings.
• Coordinate cross-functional teams to align regulatory plans with program goals.
• Manage budgeting, forecasting, and Planisware-based schedules.
• Drive process improvements and embed best practices across programs.
• Support global regulatory strategy with clear, detailed action plans.

Skills

Project management

Cross-functional teamwork

Regulatory knowledge

Process improvement

Visualization tools

Education

Bachelor's degree

Advanced degree preferred

Tools

Veeva platform

Microsoft Project

Job description

Johnson & Johnson in the United States seeks a Senior Analyst, Regulatory Program Manager (Immunology) to drive operational delivery of RPM services. You will coordinate cross-functional efforts with GRL, GRT, and partners to ensure quality, speed and alignment with program goals across multiple sites.

You will translate regulatory strategy into executable plans, manage budgets, and lead process improvements to enable accelerated filings and launches in a fast-moving immunology portfolio.